Description
Tesamorelin: The Targeted GHRH Analog for Visceral Fat Reduction and Metabolic Research
Optimize your investigations into lipodystrophy and endocrine modulation with Tesamorelin, a 44-amino acid synthetic analog of growth hormone-releasing hormone (GHRH 1-44), specifically modified with a trans-3-hexenoyl group for enhanced stability and potency. FDA-approved for HIV-associated lipodystrophy since 2010, Tesamorelin has emerged in 2025 research as a versatile tool for studying visceral adiposity, IGF-1 dynamics, and body composition in diverse metabolic models. Our lyophilized powder in a sterile vial facilitates precise reconstitution for subcutaneous protocols, supporting explorations beyond HIV into obesity, aging, and exercise recovery.
Mechanism of Action
Tesamorelin binds to GHRH receptors on pituitary somatotroph cells, stimulating pulsatile endogenous growth hormone (GH) secretion and subsequent hepatic IGF-1 production. This selective agonism promotes lipolysis in adipose tissue, particularly visceral depots, while minimizing cortisol elevation and preserving natural GH rhythms, distinguishing it from non-specific secretagogues.
Key Research Benefits
– Visceral Fat Reduction: Achieves 15-20% decreases in abdominal fat after 26 weeks in clinical models, ideal for lipodystrophy and metabolic syndrome studies.
– Improved Body Composition: Enhances lean mass and reduces waist circumference, supporting investigations into sarcopenia and HIV-related wasting.
– IGF-1 Elevation and Metabolic Health: Boosts IGF-1 levels for better insulin sensitivity and lipid profiles, aiding research on diabetes prevention and cardiovascular resilience.
– Physical Function and Recovery: When combined with exercise, it improves muscle strength and endurance in aging or chronic disease cohorts.
Dosage Considerations for Research
In experimental protocols, Tesamorelin is reconstituted with bacteriostatic water and administered subcutaneously at 1-2mg daily (5-7 days per week) for 2-3 month cycles, followed by 1-month breaks to monitor IGF-1 responses and prevent antibody formation. Titrate from 1mg to assess tolerance; store lyophilized at 2-8°C and reconstituted solutions refrigerated for up to 28 days.
**Important Disclaimer**: Tesamorelin is strictly for research purposes only . Not FDA-approved for all indications; consult regulatory guidelines and institutional protocols before use. Ongoing 2025 trials expand its applications.
Why 3L Peptides?
-
Independently lab-certified for purity and potency
-
99.44% consistent peptide quality
-
Trusted by researchers worldwide
⚠️ For research purposes only.
Reconstitution: 2ml BAC water per 10mg vial → Calculate Here
Dose: 1mg daily (20 units), 5 days on/2 days off
Cycle: 8 weeks on | Time Off: 8 weeks
Benefits: Visceral fat reduction, cognitive enhancement, lipid improvement
Notes: Evening dosing for GH pulse optimization, proven FDA-approved peptide.
- Always titrate GLP-1s slowly to avoid nausea
- Use peptidedeals.co/calculator for precise reconstitution
- Store reconstituted peptides refrigerated for up to 30 days
- Rotate injection sites to prevent lipodystrophy
- Get comprehensive blood work before and during cycles
- Bioregulators follow strict 30-day protocols, 2x yearly maximum
🔬 Legal Disclaimer: For research and educational purposes only. These compounds are not FDA-approved for human use. Always consult qualified healthcare providers and conduct thorough due diligence before use.
